NCT05825612View on ClinicalTrials.gov

EPIRUS FH Reverse Cascade Screening

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2033

Study Completion Date

May 31, 2033

Conditions

Familial Hypercholesterolemia

All Listed Sponsors

lead

Hellenic Atherosclerosis Society

OTHER

NCT05825612 - EPIRUS FH Reverse Cascade Screening | Biotech Hunter | Biotech Hunter